Drugs Real World Outcomes 
Journal Title
- Drugs Real World Outcomes
ISSN
- 2198-9788 | 2199-1154
Publisher
- Adis, Springer Healthcare
Listed on(Coverage)
| SJR | 2018-2019 |
|---|---|
| CiteScore | 2018-2019 |
| SCOPUS | 2018-2020 |
| DOAJ | 2017-2021 |
| EMBASE | 2016-2020 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | big data, drug utilization, treatment guideline adherence, patient behaviour, real world healthcare |
| Review Process | Blind peer review |
| Journal info. pages | |
| Licences | CC BY-NC |
| Copyrights | No |
| DOAJ Coverage |
|
| Subject(s) | Medicine: Therapeutics. Pharmacology | Medicine: Pharmacy and materia medica |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- NEW ZEALAND
Aime & Scopes
- Drugs - Real World Outcomes targets original research and definitive reviews regarding the use of real-world data to evaluate health outcomes and inform healthcare decision-making on drugs, devices and other interventions in clinical practice. The journal includes, but is not limited to, the following research areas: /// Using registries/databases/health records and other non-selected observational datasets to investigate: /////// drug use and treatment outcomes /////// prescription patterns /////// drug safety signals /////// adherence to treatment guidelines /////// benefit : risk profiles /////// comparative effectiveness /////// economic analyses including cost-of-illness /// Data-driven research methodologies, including the capture, curation, search, sharing, analysis and interpretation of ‘big data’ /// Techniques and approaches to optimise real-world modelling.